Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Recruiting
Phase 2
Interventional Study
Stage I Testicular Seminoma
Stage I Testicular Nonseminomatous Germ Cell Tumor
Gastrointestinal Stromal Tumors
Ovarian Germ Cell Tumor
Adenocarcinoma, Clear Cell
Borderline Ovarian Tumor
Sex Cord-Stromal Tumor
Mucinous Adenocarcinoma of Ovary
Carcinoma, Small Cell
Carcinosarcoma, Ovarian
Serous Tumor of Ovary
Glioma
Neuroendocrine Tumors
Aggressive Fibromatosis of Abdominal Wall (Disorder)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 88 (estimated)
- Sponsor
- Centre Oscar Lambret · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a train…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Positive diagnosis (anatomopathology) of tumor within 12 months
* Patient 18 years of age or older
* Patient with one of the following conditions:
1. Desmoid fibromatosis of the abdominal wall operated on or under active surveillance
2. Stage I testicular seminoma (whethe…
Contacts